T

TCI Peptide Therapeutics

4 employees

Endevica Bio is a biotechnology company that develops drugs to treat cachexia.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Peptides
Therapeutics
Drug Design
Cachexia
Pharmaceutical
Drug Development
Drug Delivery

Date founded

2009

Funding rounds raised

Total raised

$2.3M

from 1 investors over 1 rounds

T

TCI Peptide Therapeutics raised $2.3M on September 1, 2016

Investors: National Cancer Institute

FAQ